Display title | Engineering:Hybridoma technology |
Default sort key | Hybridoma technology |
Page length (in bytes) | 19,933 |
Namespace ID | 3034 |
Namespace | Engineering |
Page ID | 575184 |
Page content language | en - English |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Counted as a content page | Yes |
Page image |  |
HandWiki item ID | None |
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Page creator | imported>Gametune |
Date of page creation | 19:06, 4 February 2024 |
Latest editor | imported>Gametune |
Date of latest edit | 19:06, 4 February 2024 |
Total number of edits | 1 |
Recent number of edits (within past 90 days) | 0 |
Recent number of distinct authors | 0 |
Description | Content |
Article description: (description ) This attribute controls the content of the description and og:description elements. | Hybridoma technology is a method for producing large numbers of identical antibodies (also called monoclonal antibodies). This process starts by injecting a mouse (or other mammal) with an antigen that provokes an immune response. A type of white blood cell, the B cell, produces antibodies that bind... |